UK markets closed

Kala Pharmaceuticals, Inc. (KALA)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
6.30+0.11 (+1.78%)
At close: 04:00PM EDT
6.75 +0.45 (+7.14%)
After hours: 06:10PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-42,199
-42,199
-44,822
-142,605
-104,327
Depreciation & amortisation
303
303
537
975
912
Stock-based compensation
7,463
7,463
7,008
16,088
13,312
Change in working capital
8,895
8,895
491
-10,616
-3,573
Accounts receivable
78
78
15,138
-5,756
1,959
Inventory
7,544
7,544
1,708
-6,257
-2,368
Accounts payable
-1,904
-1,904
-2,076
3,231
-924
Other working capital
-28,537
-28,537
-79,221
-113,774
-92,636
Other non-cash items
-2,389
-2,389
2,290
22,528
2,987
Net cash provided by operating activities
-27,927
-27,927
-78,908
-108,235
-90,694
Cash flows from investing activities
Investments in property, plant and equipment
-610
-610
-313
-5,539
-1,942
Acquisitions, net
-
-
-
-4,653
0
Purchases of investments
-9,866
-9,866
-4,992
0
-113,592
Sales/maturities of investments
10,000
10,000
5,000
76,250
37,325
Net cash used for investing activities
-429
-429
62,717
70,803
-78,209
Cash flows from financing activities
Debt repayment
-10,000
-10,000
-40,039
-78,045
-32
Common stock issued
18,536
18,536
31,796
41,232
158,557
Other financing activities
-2,041
-2,041
-
-
-
Net cash used provided by (used for) financing activities
8,506
8,506
-7,942
42,554
160,628
Net change in cash
-19,850
-19,850
-24,133
5,122
-8,275
Cash at beginning of period
70,745
70,745
94,878
89,756
98,031
Cash at end of period
50,895
50,895
70,745
94,878
89,756
Free cash flow
Operating cash flow
-27,927
-27,927
-78,908
-108,235
-90,694
Capital expenditure
-610
-610
-313
-5,539
-1,942
Free cash flow
-28,537
-28,537
-79,221
-113,774
-92,636